Learn more about the program from the course coordinator Professor Paul Young
About us
The University is ranked first in Australia and fourth in the world for graduate employability in the QS Graduate Employability Rankings 2020.
Find out moreWe are ranked 18th in the world for medicine in the QS Subject Rankings 2020.
Find out more
There is a growing need for expertise in modern drug development practices, and the Master of Medicine (Pharmaceutical and Medical Device Development) program provides training in state-of-the-art techniques, approaches, and requirements for the registration of medical products.
This course is designed to introduce students to modern approaches to drug and device design and development, providing an up-to-date set of skills essential for the current industry environment.
Why study this course?
An industry-focused program, the Master of Medicine (Pharmaceutical and Medical Device Development) has been developed in partnership and is taught by leading minds in the field – in academia, regulatory affairs, intellectual property, regulator and industry bodies and a wide array of reputable industry corporates.
Who should study this course?
The program is tailored to professionals working in the pharmaceutical and bio-pharmaceutical industry, regulatory affairs, drug product evaluation, registration, and therapeutic marketing sectors.
It is designed to meet the requirements of those who work or plan to work in different pharmaceutical and medical device development areas. This course would suit graduates of health, pharmacy, medicine, science, engineering, law, business or related disciplines.
Further information:
Commonwealth Supported Places (CSP) are available for this course for eligible domestic students. This means that your course fees are subsidised by the Australian Government and you pay a student contribution amount (SCA). CSP places are limited in number and are allocated based on academic merit.
The Master of Medicine (Pharmaceutical and Medical Device Development) requires the completion of 48 credit points of units of study including:
All students in the master's program must complete compulsory units CEPI5100 Introduction to Clinical Epidemiology and the capstone unit PCOL5104 Pharm & Medical Device Development.
Stream specific units must include PCOL5101 Drugs and Devices: R and D to Registration and PCOL5102 Modern Therapeutics and Medical Devices.
If you are working full-time it is recommended you consider undertaking one or two units of study per semester. All core learning material is delivered online and some units have an intensive face-to-face teaching session.
Download our sample course diagram to learn more about what you will study as part of this degree.
Pharmaceutical and Medical Device Development course structure (pdf, 100KB)
The capstone unit PCOL5104 Pharm and Medical Device Development develops the critical thinking needed to transform a new therapeutic drug or a device into a commercially viable product.
Students will critically appraise scientific and clinical data and information in order to prepare a final scientific dossier that would be suitable for submission to the TGA, EMA or FDA.
Students will determine the submission strategy and solve clinical/scientific issues related to core aspects of the process i.e. chemistry, manufacturing, stability, safety, clinical trial or other suitable components of the process.
Admission to the Master of Medicine (Pharmaceutical and Medical Device Development) requires a medical degree from the University of Sydney or equivalent qualification.
The academic requirements that are displayed are applicable to currently available courses only, and are updated annually in October and may be changed without notice.
Students who have completed the compulsory research unit and achieved an average of at least 75% in 24 credit points of compulsory and/or stream specific units of study will be eligible to apply for the Master of Medicine (Advanced) (Pharmaceutical and Medical Device Development).
The program has been designed to ensure that the knowledge you gain can be applied to current industry needs and be readily integrated into your day-to-day work.
Graduates of this course will have the opportunity to move into careers in different areas of the pharmaceutical and medical device development industry including:
Indicative Postgraduate Student Contribution Amount
The student contribution amount for a Commonwealth Supported Place is an indication only of the amount payable in Year 1 for a standard full time load of 48 credit points (1.0 EFTSL). The exact student contribution that you pay will depend on the calendar year in which you undertake your study, and the specific units of study in which you ultimately enrol. For further information about how to calculate your specific total student contribution, please refer to the University's Tuition Fees website.
Annual review and fee increases
Importantly, student contribution amounts are subject to annual review by the University, and will increase each year of your period of study (subject to a Commonwealth specified cap), effective at the start of each calendar year.
Indicative Postgraduate Domestic Tuition Fee
The tuition fee for a domestic postgraduate student is an indication only of the fees payable in Year 1 for a standard full time load of 48 credit points (1.0 EFTSL). Depending on the calendar year in which you undertake your study, and if your study load is more or less than the 1.0 EFTSL, your tuition fee will differ from the indicative amount.
Annual review and fee increase
Importantly, tuition fees are subject to annual review by the University, and will increase each year of your period of study, effective at the start of each calendar year.
Additional incidental costs
For some courses there are incidental costs additional to the student contribution and/or course fee. Some of these incidental costs are significant, for example, course-specific materials, tools, protected clothing and equipment. Further information about these costs is available from https://sydney.edu.au/students/materials-and-equipment.html.
Visa/MasterCard/American Express/JCB surcharge
Please note that a surcharge of 1.53% will apply for payments made by Visa, MasterCard, American Express or JCB. The surcharge is subject to review and may change. Information about payment methods and the surcharge is set out at: http://sydney.edu.au/study/finances-fees-costs/fees-and-loans/paying-your-fees.html.
Potential for inaccuracy
Whilst every reasonable effort has been made to include correct and up to date information here, you are also advised to consult directly with the Student Centre so that they can provide you with specific and up to date information about fees.
Indicative International Tuition Fees for Postgraduate Students
The tuition fee for international postgraduate students is an indication only of the fees payable in Year 1 for a standard full time load of 48 credit points (1.0 EFTSL). Depending on the calendar year in which you undertake your study, and if your study load is more or less than the 1.0 EFTSL, your tuition fee will differ from the indicative amount.
Annual review and fee increases
Importantly, tuition fees are subject to annual review, and will increase each year of your period of study, effective at the start of each calendar year.
Additional incidental costs and health insurance
For some courses there are incidental costs additional to the tuition fees. Some of these incidental costs are significant, for example, course-specific materials, tools, protective clothing, and equipment. Further information about these costs is available from https://sydney.edu.au/students/materials-and-equipment.html. In addition to the fees indicated here for the course of study, International Students studying on an Australian Student Visa must have appropriate health insurance for the duration of their studies on a Student Visa through a government approved provider of the Overseas Student Health Cover (OSHC) scheme. This is a requirement of the Australian Government, unless otherwise exempted by the Government. Further information is available from https://sydney.edu.au/study/finances-fees-costs/living-costs/health-insurance.html.
Visa/MasterCard/American Express/JCB surcharge
Please note that a surcharge of 1.53% will apply for payments made by Visa, MasterCard, American Express or JCB. The surcharge is subject to review and may change. Information about payment methods and the surcharge is set out at: http://sydney.edu.au/study/finances-fees-costs/fees-and-loans/paying-your-fees.html.
Potential for inaccuracy
Whilst every reasonable effort has been made to include correct and up to date information here, you are also advised to consult directly with the Student Centre so that they can provide you with specific and up to date information about fees.
